There is a reported trend of microdosing GLP-1 drugs for potential longevity benefits, although some scientists claim there is no established link between the practice and increased longevity. The safety of microdosing GLP-1s is also being questioned, with some outlets advising caution before attempting the practice. The phenomenon appears to be part of a broader interest in peptides and alternative health approaches.